Mai Capital Management Anixa Biosciences Inc Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Mai Capital Management holds 2,770 shares of ANIX stock, worth $7,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,770
Previous 2,920
5.14%
Holding current value
$7,174
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANIX
# of Institutions
63Shares Held
5.48MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.61 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.61 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.59 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.36 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.22 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $79.4M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...